Premavision Cohort Follow-up — PrmvsionSuiv

Visual Disorder Clinical Trial

Official title:
Visual Maturation in Prematurely Born Infants According to Factors Influencing Its Development. Premavision Follow-up at 18 Months Corrected Age, 4 and 7 Years of Age.

Status Terminated

Clinical Trial Summary

This study aim at following a cohort of prematurely born infants at 18 months corrected age, 4 and 7 years of age. This cohort had an evaluation of visual maturation at term equivalent age (TEA) with factors associated with impaired visual maturation. (PREMAVISION-CLinicalTrials.gov ID: NCT02890251). In this follow-up study, prematurely born infants vision will be compared to term born infants matched for postnatal age.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03207477
Study type	Interventional
Source	Central Hospital, Nancy, France
Contact
Status	Terminated
Phase	N/A
Start date	November 20, 2017
Completion date	June 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05102955` - Turkish Validity and Reliability of the Visual Function Classification System (VFCS)
Recruiting	`NCT05967078` - ExerG: Video Game-based Physical Cognitive Training for Patients: a Usability Study	N/A
Completed	`NCT02543528` - A Clinical Trial to Evaluate Investigational Silicone Hydrogel Contact Lenses Worn Continuously for One Week	N/A
Completed	`NCT05608811` - The Effect of Social Skills Training in Visually Impaired Adolescents	N/A
Completed	`NCT02669095` - Clinical Evaluation of Approved and Investigational Contact Lenses	N/A
Completed	`NCT04277754` - Motor and Visual Development in 2 Year Olds